What is he best known for?
The fields of study he is best known for:
- Apoptosis
- Internal medicine
- Cancer
The scientist’s investigation covers issues in Programmed cell death, Necroptosis, Apoptosis, Cell biology and Necrosis.
Andreas Linkermann has researched Programmed cell death in several fields, including Autophagy, Lipid peroxidation, Neurodegeneration, Signal transduction and Physiology.
His work carried out in the field of Necroptosis brings together such families of science as Pyroptosis and Mitochondrial permeability transition pore.
His study in Apoptosis is interdisciplinary in nature, drawing from both Neuroscience, Immunology and Pharmacology.
Many of his research projects under Cell biology are closely connected to Mitochondrial depletion with Mitochondrial depletion, tying the diverse disciplines of science together.
His Necrosis study incorporates themes from Cancer research and RIPK1.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. (1421 citations)
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease (1069 citations)
What are the main themes of his work throughout his whole career to date?
Andreas Linkermann mostly deals with Programmed cell death, Necroptosis, Cell biology, Necrosis and Apoptosis.
His research on Programmed cell death focuses in particular on Mitochondrial permeability transition pore.
His Necroptosis research integrates issues from Pyroptosis, Immunology, Acute kidney injury and Transplantation.
His study in the field of Mitochondrion also crosses realms of Fusion protein.
The concepts of his Necrosis study are interwoven with issues in Tumor necrosis factor alpha, Cell, Bioinformatics, Inflammation and Reperfusion injury.
His studies deal with areas such as Cancer, Neurodegeneration and Transplant rejection as well as Apoptosis.
He most often published in these fields:
- Programmed cell death (51.59%)
- Necroptosis (42.86%)
- Cell biology (30.16%)
What were the highlights of his more recent work (between 2018-2021)?
- Programmed cell death (51.59%)
- Cancer research (25.40%)
- Necroptosis (42.86%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Programmed cell death, Cancer research, Necroptosis, Inflammation and Necrosis.
His study on Programmed cell death is covered under Apoptosis.
Andreas Linkermann has included themes like Acute kidney injury, Pyroptosis, Ventricular remodeling and Transplantation in his Necroptosis study.
The various areas that Andreas Linkermann examines in his Pyroptosis study include Caspase and Cell biology.
Andreas Linkermann works mostly in the field of Inflammation, limiting it down to concerns involving Tumor necrosis factor alpha and, occasionally, Caspase 8, Immune system and Proinflammatory cytokine.
His Necrosis research incorporates themes from Cancer, Mitochondrion, Immunogenicity and Mitochondrial permeability transition pore.
Between 2018 and 2021, his most popular works were:
- Ferroptosis as a target for protection against cardiomyopathy. (209 citations)
- Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation (66 citations)
- The pathological features of regulated necrosis. (47 citations)
In his most recent research, the most cited papers focused on:
- Apoptosis
- Internal medicine
- Cancer
Andreas Linkermann mainly focuses on Programmed cell death, Necroptosis, Apoptosis, Cancer research and Transplantation.
Andreas Linkermann integrates several fields in his works, including Programmed cell death and HMOX1.
His Necroptosis study incorporates themes from Necrosis, Antibody, Heart transplantation and Cell biology.
His study in the field of Mitochondrion is also linked to topics like Calcium oxalate.
His research integrates issues of Human leukocyte antigen, Cytochalasin D, Actin cytoskeleton and Stress fiber in his study of Apoptosis.
He combines subjects such as Coagulative necrosis, Inflammation, Immunology and Kinase with his study of Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
